XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析

◆英語タイトル:XBiotech Inc (XBIT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2540713FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company offers monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed for the treatment of metastatic colorectal cancer. XBiotech offers clinical trial activity services, oncology, MRSA, and dermatology related solutions. The company develops a True Human technology to discover and develop targeted antibody candidates. It pipeline includes candidates, which target various therapeutic areas such as pyoderma gangrenosum, plaque psoriasis, influenza and Type II diabetes, among others. It has operations in the US, Switzerland, Japan and Germany. XBiotech is headquartered in Austin, Texas, the US.

XBiotech Inc Key Recent Developments

Jan 19,2021: XBiotech announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
Sep 21,2020: XBiotech developing true human antibody combination as candidate treatment for influenza-COVID-19 co-infections
Jul 22,2020: XBiotech achieves milestone for production of its new potential blockbuster Anti-IL-1? therapy
Jul 14,2020: XBiotech announces discovery that blocking Interleukin-1a reduces brain injury and neurological deficit after stroke
May 01,2020: XBiotech identifies “Super Bloods” for the development of a True Human COVID-19 Therapy

This comprehensive SWOT profile of XBiotech Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of XBiotech Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

XBiotech Inc – Key Information
XBiotech Inc – Overview
XBiotech Inc – Key Employees
XBiotech Inc – Key Employee Biographies
XBiotech Inc – Key Operational Heads
XBiotech Inc – Major Products and Services
XBiotech Inc – History
XBiotech Inc – Company Statement
XBiotech Inc – Locations And Subsidiaries
XBiotech Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

XBiotech Inc – Business Description
XBiotech Inc – Corporate Strategy
XBiotech Inc – SWOT Analysis
SWOT Analysis – Overview
XBiotech Inc – Strengths
XBiotech Inc – Weaknesses
XBiotech Inc – Opportunities
XBiotech Inc – Threats
XBiotech Inc – Key Competitors

Section 3 – Company Financial Performance Charts

XBiotech Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

XBiotech Inc, Key Information
XBiotech Inc, Key Ratios
XBiotech Inc, Share Data
XBiotech Inc, Major Products and Services
XBiotech Inc, History
XBiotech Inc, Key Employees
XBiotech Inc, Key Employee Biographies
XBiotech Inc, Key Operational Heads
XBiotech Inc, Other Locations
XBiotech Inc, Subsidiaries
XBiotech Inc, Key Competitors
XBiotech Inc, SWOT Analysis
XBiotech Inc, Ratios based on current share price
XBiotech Inc, Annual Ratios
XBiotech Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • Lianhe Chemical Technology Co., Ltd. (002250):企業の財務・戦略的SWOT分析
    Lianhe Chemical Technology Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Orion Corp (ORNBV):製薬・医療:M&Aディール及び事業提携情報
    Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous …
  • Sanquin Blood Supply Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Acushnet Holdings Corp. (GOLF):企業の財務・戦略的SWOT分析
    Acushnet Holdings Corp. (GOLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Absher Construction Company:企業の戦略・SWOT・財務情報
    Absher Construction Company - Strategy, SWOT and Corporate Finance Report Summary Absher Construction Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Olympus America Inc-医療機器分野:企業M&A・提携分析
    Summary Olympus America Inc (Olympus America), a subsidiary of Olympus Corporation is medical device company that designs, develops and manufactures medical and surgical products, industrial measurement and imaging instruments, life science imaging systems, and cameras and audio products. The compan …
  • Virgin Group Ltd.:企業のM&A・事業提携・投資動向
    Virgin Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • SpectraScience Inc (SCIE):企業の財務・戦略的SWOT分析
    SpectraScience Inc (SCIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OS …
  • Apyx Medical Corp (BVX):企業の財務・戦略的SWOT分析
    Summary Apyx Medical Corp (Apyx Medical) formerly known as Bovie Medical Corp is a medical technology company. The company manufactures and develops cosmetic and surgical products. The company also develops J-Plasma, a helium-based plasma surgical product for cutting, coagulation and ablation of sof …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Dr. Reddy’s Research and Development BV-製薬・医療分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • LED Dental Inc:医療機器:M&Aディール及び事業提携情報
    Summary LED Dental Inc (LED Dental), a subsidiary of LED Medical Diagnostics Inc is a medical device company that offers dental products. The company develops and commercializes detection technologies utilizing tissue fluorescence visualization. Its products include dental imaging systems, CT imagin …
  • Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Damac Real Estate Development Ltd:企業の戦略・SWOT・財務分析
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆